Last Price
2.009
Today's Change
-0.26 (11.45%)
Day's Change
1.92 - 2.27
Trading Volume
173,811
Market Cap
3 Million
Shares Outstanding
1 Million
Avg Volume
5,323,677
Avg Price (50 Days)
1.33
Avg Price (200 Days)
6.60
PE Ratio
-0.15
EPS
-13.22
Earnings Announcement
26-Feb-2025
Previous Close
2.27
Open
2.17
Day's Range
1.922 - 2.2786
Year Range
0.207 - 13.558
Trading Volume
173,811
1 Day Change
-11.45%
5 Day Change
-9.46%
1 Month Change
-27.96%
3 Month Change
-59.88%
6 Month Change
-82.24%
Ytd Change
0.00%
1 Year Change
-81.56%
3 Year Change
-79.24%
5 Year Change
-79.90%
10 Year Change
-79.90%
Max Change
-79.90%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.